A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas.
Aoki
K
K
Shimada
Y
Y
Okazaki
N
N
Tajiri
H
H
Nose
H
H
Okada
S
S
Shirao
K
K
Yokota
T
T
Yoshida
S
S
Saitoh
D
D
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D004341:Drug Evaluation; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D015251:Epirubicin